Maze Therapeutics, Inc. MAZE
32.43 USD +1.23 (+3.94%)
Regular-session close
32.46 +0.03 +0.09%
After hours · Nov 19, 7:43 PM ET
30.69 Day range 32.74
21.95 52-week range 53.65
- YTD
- -21.72%
- 1 year
- -8.75%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -142.90M | 57.59M | -98.55M | -111.03M | |
| -131.12M | 3.40M | -100.42M | -114.94M | |
| -3.05 | 1.25 | -43.89 | -5.93 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| 190.34M | 197.90M | 30.25M | 101.13M | |
| 397.13M | 240.54M | 71.50M | 149.96M | |
| 42.16M | 43.64M | 61.45M | 48.51M | |
| 23.31M | 26.63M | 49.62M | 32.05M | |
| 354.97M | -311.18M | -373.85M | -282.46M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 |
|---|---|---|---|---|
| -111.94M | 75.95M | -86.83M | -99.20M | |
| -170.96M | -1.15M | -441.00K | -3.17M | |
| 275.34M | 92.85M | 16.39M | 1.73M | |
| -794.00K | -1.15M | -441.00K | -1.97M | |
| -7.57M | 167.65M | -70.88M | -100.64M |
